Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter / Tate, Jillian R.

12 Issues per year


IMPACT FACTOR 2016: 3.432

CiteScore 2016: 2.21

SCImago Journal Rank (SJR) 2016: 1.000
Source Normalized Impact per Paper (SNIP) 2016: 1.112

Online
ISSN
1437-4331
See all formats and pricing
More options …
Volume 36, Issue 10 (Oct 1998)

Issues

Activated Immune System in Patients with Huntington's Disease

Friedrich Leblhuber / Johannes Walli / Kurt Jellinger / Gernot P Tilz / Bernhard Widner / Franco Laccone / Dietmar Fuchs
Published Online: 2005-06-01 | DOI: https://doi.org/10.1515/CCLM.1998.132

Abstract

Abnormalities of immune system compartments were determined in 12 patients with Huntington's disease (eight males, four females; age 42.4 ± 11.7 years) and 11 controls (7 males, 4 females; age 47.0 ± 12.0). All patients were free from infectious diseases. Serum concentrations of a panel of serum soluble markers of immune activation were investigated, namely neopterin, 55-kDa-type soluble tumor necrosis factor receptor (sTNF-R), interleukin-2-receptor (sIL-2R), kynurenine, tryptophan, immunoglobulins (Ig) A, M and G as well as routine laboratory tests. Compared to controls, we found significantly higher serum levels of IgA (p < 0.01), sTNF-R, sIL-2R, neopterin, and complement component C3 (all p < 0.05), and serum tryptophan was decreased (p < 0.001). Higher concentrations of circulating immune complexes, cardiolipin antibodies, IgM, neopterin and lower tryptophan were associated with loss of cognitive function as assessed by the minimental-test. Five patients died within 1 year after measurements were performed. In these patients IgM, circulating immune complexes and neopterin concentrations were higher compared to survivors and serum tryptophan was lower. The data indicate an activation of various immune system compartments in Huntington's disease and that systemic immunological alterations might be important in the course of the disease.

About the article

Published Online: 2005-06-01

Published in Print: 1998-10-13


Citation Information: Clinical Chemistry and Laboratory Medicine, ISSN (Print) 1434-6621, DOI: https://doi.org/10.1515/CCLM.1998.132.

Export Citation

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Qiaojun Fang, Andrew Strand, Wendy Law, Vitor M. Faca, Matthew P. Fitzgibbon, Nathalie Hamel, Benoit Houle, Xin Liu, Damon H. May, Gereon Poschmann, Line Roy, Kai Stühler, Wantao Ying, Jiyang Zhang, Zhaobin Zheng, John J. M. Bergeron, Sam Hanash, Fuchu He, Blair R. Leavitt, Helmut E. Meyer, Xiaohong Qian, and Martin W. McIntosh
Molecular & Cellular Proteomics, 2009, Volume 8, Number 3, Page 451
[2]
Laura Taylor Alto, Xi Chen, Kelly A. Ruhn, Isaac Treviño, Malú G. Tansey, and Christopher Mark Norris
PLoS ONE, 2014, Volume 9, Number 5, Page e96544
[3]
Faith H. Brennan, John D. Lee, Marc J. Ruitenberg, and Trent M. Woodruff
Seminars in Immunology, 2016, Volume 28, Number 3, Page 292
[4]
Michael D. Lovelace, Bianca Varney, Gayathri Sundaram, Matthew J. Lennon, Chai K. Lim, Kelly Jacobs, Gilles J. Guillemin, and Bruce J. Brew
Neuropharmacology, 2017, Volume 112, Page 373
[5]
Barbara Strasser, Kathrin Becker, Dietmar Fuchs, and Johanna M. Gostner
Neuropharmacology, 2017, Volume 112, Page 286
[6]
Gabriele Costantino
Expert Opinion on Therapeutic Targets, 2009, Volume 13, Number 2, Page 247
[7]
J.A. Bouwens, A.A.M. Hubers, E. van Duijn, C.M. Cobbaert, R.A.C. Roos, R.C. van der Mast, and E.J. Giltay
European Neuropsychopharmacology, 2014, Volume 24, Number 8, Page 1248
[8]
H. Runne, A. Kuhn, E. J. Wild, W. Pratyaksha, M. Kristiansen, J. D. Isaacs, E. Regulier, M. Delorenzi, S. J. Tabrizi, and R. Luthi-Carter
Proceedings of the National Academy of Sciences, 2007, Volume 104, Number 36, Page 14424
[9]
Wanda Kwan, Ulrike Träger, Dimitrios Davalos, Austin Chou, Jill Bouchard, Ralph Andre, Aaron Miller, Andreas Weiss, Flaviano Giorgini, Christine Cheah, Thomas Möller, Nephi Stella, Katerina Akassoglou, Sarah J. Tabrizi, and Paul J. Muchowski
Journal of Clinical Investigation, 2012, Volume 122, Number 12, Page 4737
[10]
Peter Svoboda, Seong-Hee Ko, BeLong Cho, Sang-Ho Yoo, Seong-Won Choi, Sang-Kyu Ye, Hiroshi Kasai, and Myung-Hee Chung
Analytical Biochemistry, 2008, Volume 383, Number 2, Page 236
[12]
Trevor W. Stone, Caroline M. Forrest, Nicholas Stoy, and L. Gail Darlington
Journal of Neural Transmission, 2012, Volume 119, Number 2, Page 261
[13]
Christiane Enzinger, Barbara Wirleitner, Günther Böck, Gabriele Baier-Bitterlich, and Dietmar Fuchs
Neuroscience Letters, 2001, Volume 316, Number 3, Page 157
[14]
Bernhard Widner, Norbert Sepp, Elisabeth Kowald, Ulrike Ortner, Barbara Wirleitner, Peter Fritsch, Gabriele Baier-Bitterlich, and Dietmar Fuchs
Immunobiology, 2000, Volume 201, Number 5, Page 621
[15]
Lukasz R. Kolodziej, Ewa M. Paleolog, and Richard O. Williams
Amino Acids, 2011, Volume 41, Number 5, Page 1173
[16]
Katharina Schröcksnadel, Barbara Wirleitner, Christiana Winkler, and Dietmar Fuchs
Clinica Chimica Acta, 2006, Volume 364, Number 1-2, Page 82
[17]
Harikesh Kalonia, Puneet Kumar, and Anil Kumar
Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2011, Volume 35, Number 2, Page 607
[21]
Harikesh Kalonia, Puneet Kumar, and Anil Kumar
Behavioural Brain Research, 2011, Volume 216, Number 1, Page 220
[22]
Soo-Youl Kim, Thomas M Jeitner, and Peter M Steinert
Neurochemistry International, 2002, Volume 40, Number 1, Page 85
[25]
Trevor W Stone
Progress in Neurobiology, 2001, Volume 64, Number 2, Page 185
[26]
Tony Wyss-Coray and Lennart Mucke
Neuron, 2002, Volume 35, Number 3, Page 419
[27]
Dietmar Fuchs, Bernhard Widner, and Friedrich Leblhuber
The Lancet, 1999, Volume 353, Number 9149, Page 325
[28]
Friedrich Leblhuber, Johannes Walli, Ulrike Demel, Gernot P. Tilz, Bernhard Widner, and Dietmar Fuchs
Clinical Chemistry and Laboratory Medicine, 1999, Volume 37, Number 4
[29]
Dietmar Fuchs, Matthias Jaeger, Bernhard Widner, Barbara Wirleitner, Erika Artner-Dworzak, and Friedrich Leblhuber
Clinical Chemistry and Laboratory Medicine, 2001, Volume 39, Number 8
[30]
Malcolm Ward and Emma Louise Schofield
Therapy, 2010, Volume 7, Number 4, Page 321
[31]
Gustavo Pacheco-López, Maj-Britt Niemi, Wei Kou, Andre Bildhäuser, Claus M. Gross, Marion U. Goebel, Adriana Del Rey, Hugo O. Besedovsky, and Manfred Schedlowski
Journal of Neurochemistry, 2003, Volume 86, Number 4, Page 1024
[32]
Korrapati V. Sathyasaikumar, Erin K. Stachowski, Laura Amori, Paolo Guidetti, Paul J. Muchowski, and Robert Schwarcz
Journal of Neurochemistry, 2010
[33]
Caroline M. Forrest, Gillian M. Mackay, Nicholas Stoy, Sarah L. Spiden, Rohan Taylor, Trevor W. Stone, and L. Gail Darlington
Journal of Neurochemistry, 2010, Volume 112, Number 1, Page 112
[34]
Journal of the American Geriatrics Society, 2003, Volume 51, Number 5, Page 721
[35]
N. Stoy, G. M. Mackay, C. M. Forrest, J. Christofides, M. Egerton, T. W. Stone, and L. G. Darlington
Journal of Neurochemistry, 2005, Volume 93, Number 3, Page 611

Comments (0)

Please log in or register to comment.
Log in